Cargando…
Inhibitory Effects of KP-A159, a Thiazolopyridine Derivative, on Osteoclast Differentiation, Function, and Inflammatory Bone Loss via Suppression of RANKL-Induced MAP Kinase Signaling Pathway
Abnormally elevated formation and activation of osteoclasts are primary causes for a majority of skeletal diseases. In this study, we found that KP-A159, a newly synthesized thiazolopyridine derivative, inhibited osteoclast differentiation and function in vitro, and inflammatory bone loss in vivo. K...
Autores principales: | Ihn, Hye Jung, Lee, Doohyun, Lee, Taeho, Kim, Sang-Hyun, Shin, Hong-In, Bae, Yong Chul, Hong, Jung Min, Park, Eui Kyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4633183/ https://www.ncbi.nlm.nih.gov/pubmed/26536233 http://dx.doi.org/10.1371/journal.pone.0142201 |
Ejemplares similares
-
Inhibitory Effect of KP-A038 on Osteoclastogenesis and Inflammatory Bone Loss Is Associated With Downregulation of Blimp1
por: Ihn, Hye Jung, et al.
Publicado: (2019) -
Suppressive effects of (-)-tubaic acid on RANKL-induced osteoclast differentiation and bone resorption
por: Lim, Soomin, et al.
Publicado: (2023) -
OCLI-023, a Novel Pyrimidine Compound, Suppresses Osteoclastogenesis In Vitro and Alveolar Bone Resorption In Vivo
por: Ihn, Hye Jung, et al.
Publicado: (2017) -
Inhibitory Effect of Purpurogallin on Osteoclast Differentiation In Vitro through the Downregulation of c-Fos and NFATc1
por: Kim, Kiryeong, et al.
Publicado: (2018) -
Afatinib ameliorates osteoclast differentiation and function through downregulation of RANK signaling pathways
por: Ihn, Hye Jung, et al.
Publicado: (2017)